Application of detection of mutations in blood and immunodeficiency genes in the diagnosis of HLH patients. - PubMed - NCBI

Application of detection of mutations in blood and immunodeficiency genes in the diagnosis of HLH patients. - PubMed - NCBI

Exp Hematol. 2019 Sep 25. pii: S0301-472X(19)31026-4. doi: 10.1016/j.exphem.2019.09.024. [Epub ahead of print]

Application of detection of mutations in blood and immunodeficiency genes in the diagnosis of HLH patients.

Mo W1, Wei W2, Sun Y3, Yang Y1, Guan Z1, Li M1, Zhu P4, Chi Z5.

Author information

1

The First Affiliated Hospital/School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, China.

2

Kangso Medical Inspection, Beijing, China.

3

College of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.

4

Hematology Research Laboratory, Peking University First Hospital, Beijing, China. Electronic address: zhuping@bjmu.edu.cn.

5

The First Affiliated Hospital/School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, China. Electronic address: zhchi33@126.com.

Abstract

To investigate the value of genetic mutations in the pathogenesis and differential diagnosis of hemophagocytic lymphohistiocytosis (HLH), the mutations related to blood and immune deficiency genes were analyzed in patients with HLH. Peripheral blood samples from 33 children diagnosed with HLH according to the 2004 diagnostic criteria were collected, and 317 gens related with blood system diseases and 562 genes related with immunodeficiency were detected by the second generation targeted sequencing technology, bioinformatic analysis and parental verification analysis. A total of 159 mutations related with blood system diseases and immunodeficiency were found in 33 patients, including 7 HLH-related gene mutations (UNC13D, XIAP, LYST, STX11, ITK, PRF1 and SRGN) in 12 patients. UNC13D was found in 6 patients, with the highest frequency. Two cases (6.1%, 2/33) were diagnosed as primary hemophagocytic lymphohistiocytosis (pHLH), and six cases (18.2%, 6/33) were diagnosed as primary immunodeficiency disease (PID) or hereditary hematopathy, and the others were diagnosed as secondary hemophagocytic lymphohistiocytosis (sHLH). It is necessary to detect blood and immunodeficiency genes to exclude the possibility of pHLH, PID or hereditary hematopathy associated with HLH for children.

Copyright © 2019. Published by Elsevier Inc.

KEYWORDS:

High throughput sequencing; Molecular diagnosis; Primary hemophagocytic lymphohistiocytosis

PMID:

 

31562900

 

DOI:

 

10.1016/j.exphem.2019.09.024